Clinical implications of chronic heart failure phenotypes defined by cluster analysis. - Wikidata - wikimedia - TriplyDB

Clinical implications of chronic heart failure phenotypes defined by cluster analysis.

Clinical implications of chronic heart failure phenotypes defined by cluster analysis.

http://www.wikidata.org/entity/Q30604593

about

Patient selection in heart failure with preserved ejection fraction clinical trials The emerging role of epigenetics in pulmonary arterial hypertension: an important avenue for clinical trials (2015 Grover Conference Series)Addressing the Heterogeneity of Heart Failure in Future Randomized Trials.Novel approach to classifying patients with pulmonary arterial hypertension using cluster analysis.Metabolic Dysfunction in Heart Failure: Diagnostic, Prognostic, and Pathophysiologic Insights From Metabolomic Profiling.Cardiovascular Late Effects and Exercise Treatment in Breast Cancer: Current Evidence and Future Directions Clinical Implications of Cluster Analysis-Based Classification of Acute Decompensated Heart Failure and Correlation with Bedside Hemodynamic Profiles.Molecular phenotyping of clinical AKI with novel urinary biomarkers.Characterization of subgroups of heart failure patients with preserved ejection fraction with possible implications for prognosis and treatment response.Learning Clinical Workflows to Identify Subgroups of Heart Failure Patients.Cluster analysis: a new approach for identification of underlying risk factors for coronary artery disease in essential hypertensive patients Pathophysiology and clinical evaluation of acute heart failure.Clinical Phenotyping of Heart Failure with Biomarkers: Current and Future Perspectives.Towards Precision in HF Pharmacotherapy.The Potential of Clinical Phenotyping of Heart Failure With Imaging Biomarkers for Guiding Therapies: A Focused Update.Precision medicine informatics.Association of Atrial Fibrillation Clinical Phenotypes with Treatment Patterns and Outcomes: A Multicenter Registry Study.Vascular phenotypes of acute decompensated vs. new-onset heart failure: treatment implications.Machine Learning Methods Improve Prognostication, Identify Clinically Distinct Phenotypes, and Detect Heterogeneity in Response to Therapy in a Large Cohort of Heart Failure Patients.Multimorbidity in patients with heart failure from 11 Asian regions: A prospective cohort study using the ASIAN-HF registry.Disrupting Virchow's triad: can factor X inhibition reduce risk of adverse outcomes in patients with ischaemic cardiomyopathy?Reclassifying heart failure: time for disruptive innovation?Determining exercise training responders through inflammatory status in heart failure.Emerging Role of Precision Medicine in Cardiovascular Disease.Inflammatory biomarkers and effect of exercise on functional capacity in patients with heart failure: Insights from a randomized clinical trial

P2860

Q27015845-ED95CFEA-F272-41B0-A5C6-304D48962480 Q28069443-91D05381-04EF-42E7-80D3-D04604639F80 Q30234708-2E7DFE75-18B6-45CE-B42A-461924AA2897 Q33788539-77684B94-1A46-4262-8FFE-42E5E4EAF817 Q33892283-753F3611-3EE0-4B36-93E2-6C91F84A0CA2 Q33907581-3C3EABAD-823F-466F-81B2-3299975185FD Q35913203-5C17D716-E025-4BE5-86E5-3D6D6ACEC824 Q36017608-8BEFC855-7649-426E-AB31-506921DA644A Q36303452-0CDF1517-A204-4972-8DBC-03E0CF659EC8 Q37676673-4D8EC5F0-585E-4AC6-A41A-05A7FA6EB78A Q37683957-64770236-341C-45D8-851E-6CD74FFC7C7E Q38586834-59585A30-3DDB-4FA2-812E-94DEE3239DED Q38756838-A34BEFD3-893D-45AF-B0C3-C2BC05E54088 Q38758440-095B3C59-B205-4EB5-BA5A-CC1E5B2BF82B Q41693071-577E3AF6-BCCA-4736-A455-594FE0730CC1 Q42507839-10AB326A-1F9F-49FA-A9A8-319BA3E8A01D Q46731614-78B4CA00-A2B3-40B7-A013-4D1C2CC4A710 Q47900509-C9519243-C150-40EB-B4B4-F015D32F5B08 Q52323086-2ACD4F13-6A83-4439-B2B9-BBD75F3F70EB Q52627988-31120BE9-5452-4090-B0C0-A55CCF3868B2 Q52660416-A53D59A9-750A-4779-8F30-296910412D31 Q53364388-024B9352-6345-427E-9FB8-5D553C51BB34 Q53710827-06091EE4-DEBE-474F-AEF2-6CA77610BC5D Q53748314-EE528691-FFAA-466B-AF39-B43EB46F4B79 Q58854099-F979AB16-4D9B-4C11-AFC5-86DB2BE3EBDF

P2860

Clinical implications of chronic heart failure phenotypes defined by cluster analysis.

http://www.wikidata.org/entity/Q30604593

description

2014 nî lūn-bûn

@nan

2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Clinical implications of chronic heart failure phenotypes defined by cluster analysis.

@ast

Clinical implications of chronic heart failure phenotypes defined by cluster analysis.

@en

type

label

Clinical implications of chronic heart failure phenotypes defined by cluster analysis.

@ast

Clinical implications of chronic heart failure phenotypes defined by cluster analysis.

@en

prefLabel

Clinical implications of chronic heart failure phenotypes defined by cluster analysis.

@ast

Clinical implications of chronic heart failure phenotypes defined by cluster analysis.

@en

P1433

Q30604593-A13D3FD4-30B9-42B0-B2FC-CA1C283CA88D

P1476

Q30604593-C4A8CD58-3D4F-454B-864D-8F4E37B4CC47

P2093

Q30604593-1A77F9F3-496D-4B7A-BE4B-5E47D0CD8283

Q30604593-27364EB3-0678-4DB8-9BBD-470C57F3384D

Q30604593-46A1C77B-9702-4F73-8A50-846A3E9FCEE5

Q30604593-68948FC6-596D-4A71-8AC9-E8173D6DFD13

Q30604593-7EEA3780-1D68-4C3E-8740-ED8661262051

Q30604593-A3239540-9E6C-4F37-9571-CC123FE5F3D5

Q30604593-AD4AA487-1480-4427-A138-12561C1BE4F8

Q30604593-BFDC6247-CB5C-4554-B432-B782665C282F

Q30604593-C95933FF-D635-48A3-9BE7-C7AC8178D54D

P2860

Q30604593-08C176CC-F8B4-48E8-BD8E-7235EB082438

Q30604593-0A33B629-0D60-4488-BCF8-4759E1323CC8

Q30604593-3014442A-E355-4AF3-85DA-85AD2E38258E

Q30604593-392945DC-6496-4CAC-820B-D3C745F43261

Q30604593-3DF1DBA2-D850-41D0-8B94-058503D9BEBD

Q30604593-513354E9-979E-4317-8953-1EC8B346553B

Q30604593-5545B5AF-A283-4361-B384-579D7A163B83

Q30604593-58523B8F-E2DE-45D7-8C13-D547FC938871

Q30604593-5ECBCB61-8EB6-48AE-88D5-5B0BDD9B9B4C

Q30604593-61D2840C-7BBA-416C-BDC3-D8A887ECBF68

P304

Q30604593-4287B7CD-83F1-4337-B038-215874E0B9FA

P31

Q30604593-E5643979-47EE-43D3-9579-BABF51CEE202

P356

Q30604593-4944CB9B-69AD-4C55-930E-E7088CEE7B19

P407

Q30604593-D5C36937-9984-432E-9E8A-683AD4B7C2C3

P433

Q30604593-3210CA4F-48BB-4066-AC5E-8BE9836AE248

P478

Q30604593-14D9CBA5-84C8-4DE7-9B8A-12D23843D17E

P50

Q30604593-8C46E853-05CF-4ADB-A7D9-D2523127832E

P577

Q30604593-999BC668-96EB-40A3-B080-86C57370D585

P698

Q30604593-AC8C741B-2EE6-41CA-8021-940307A65A98

P921

Q30604593-878D91F4-9361-4E3E-9BD6-B34ED2F1219C

P932

Q30604593-3CA6524D-06AB-49B4-8B7F-95631505CFCE

P356

J.JACC.2014.07.979

P1433

Journal of the American College of Cardiology

P1476

Clinical implications of chronic heart failure phenotypes defined by cluster analysis.

@en

P2093

Dalane W Kitzman

http://www.w3.org/2001/XMLSchema#string

David J Whellan

http://www.w3.org/2001/XMLSchema#string

Emily O'Brien

http://www.w3.org/2001/XMLSchema#string

G Michael Felker

http://www.w3.org/2001/XMLSchema#string

Ileana L Piña

http://www.w3.org/2001/XMLSchema#string

Kerry L Lee

http://www.w3.org/2001/XMLSchema#string

Michael J Pencina

http://www.w3.org/2001/XMLSchema#string

Phillip J Schulte

http://www.w3.org/2001/XMLSchema#string

Tariq Ahmad

http://www.w3.org/2001/XMLSchema#string

P2860

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the

MicroRNAs in the human heart: a clue to fetal gene reprogramming in heart failure

2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

Efficacy of angiotensin-converting enzyme inhibition in reducing progression from asymptomatic left ventricular dysfunction to symptomatic heart failure in black and white patients.

Cluster analysis for identifying sub-groups and selecting potential discriminatory variables in human encephalitis.

Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial

Soluble ST2 in ambulatory patients with heart failure: Association with functional capacity and long-term outcomes.

The heterogeneity of early Parkinson's disease: a cluster analysis on newly diagnosed untreated patients.

Transforming growth factor-beta 1 hyperexpression in African-American hypertensives: A novel mediator of hypertension and/or target organ damage.

P304

1765-1774

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JACC.2014.07.979

http://www.w3.org/2001/XMLSchema#string

P407

P433

17

http://www.w3.org/2001/XMLSchema#string

P478

64

http://www.w3.org/2001/XMLSchema#string

P50

Christopher M O'Connor

P577

2014-10-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25443696

http://www.w3.org/2001/XMLSchema#string

P921

P932

4254424

http://www.w3.org/2001/XMLSchema#string